IGC Pharma, Inc. reports

Company location: Potomac, MD
Fiscal year end: 31 December

IGC Pharma, Inc. has filed 812 SEC EDGAR filings since 13 May 2005

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 126-150 of 590 matching filings.

Per page

25

Current page

6

8-K File 001-32830

FORM 8-K

Filing date: 23 Mar 2022
Reporting date: 23 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-32830

FORM 10-Q

Filing date: 10 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 28 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 26 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32830

FORM 8-K

Filing date: 18 Jan 2022
Reporting date: 18 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 27 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Dec 2021
Reporting date: 20 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-261861

FORM S-8

Filing date: 23 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-32830

FORM 8-K

Filing date: 02 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32830

FORM 8-K

Filing date: 19 Nov 2021
Reporting date: 18 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-32830

FORM 10-Q

Filing date: 29 Oct 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-32830

FORM 8-K

Filing date: 15 Oct 2021
Reporting date: 15 Oct 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

144 File 001-32830

FORM 144

Filing date: 17 Sep 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-32830

FORM DEF 14A

Filing date: 15 Sep 2021
Reporting date: 15 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

3/A filing

Filing date: 15 Sep 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

4/A filing

Filing date: 15 Sep 2021
Reporting date: 15 Sep 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

5/A

5/A filing

Filing date: 15 Sep 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-32830

FORM 10-Q

Filing date: 11 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-32830

FORM 10-K

Filing date: 14 Jun 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

3 filing

Filing date: 04 Jun 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

5

5 filing

Filing date: 17 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 14 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 14 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .